Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey ; volume:38 ; number:9 ; day:4 ; month:4 ; year:2023 ; pages:3035-3042 ; date:9.2023
Pediatric nephrology ; 38, Heft 9 (4.4.2023), 3035-3042, 9.2023
- Creator
-
Zurowska, Aleksandra
Drozynska-Duklas, Magdalena
Topaloglu, Rezan
Bouts, Antonia
Boyer, Olivia
Shenoy, Mohan
Vivarelli, Marina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00467-023-05913-1
- URN
-
urn:nbn:de:101:1-2023110413050000645322
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zurowska, Aleksandra
- Drozynska-Duklas, Magdalena
- Topaloglu, Rezan
- Bouts, Antonia
- Boyer, Olivia
- Shenoy, Mohan
- Vivarelli, Marina
- SpringerLink (Online service)
Other Objects (12)
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
The glomerular permeability factors in idiopathic nephrotic syndrome
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
The role of the immune system in idiopathic nephrotic syndrome
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Congenital nephrotic syndrome
Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
The glomerular permeability factors in idiopathic nephrotic syndrome
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
The role of the immune system in idiopathic nephrotic syndrome
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Congenital nephrotic syndrome
Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
The glomerular permeability factors in idiopathic nephrotic syndrome
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
The role of the immune system in idiopathic nephrotic syndrome
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Congenital nephrotic syndrome
Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome